dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Arteaga Henriquez, Gara |
dc.contributor.author | Simon, Maria S. |
dc.contributor.author | Burger, Bianka |
dc.contributor.author | Weidinger, Elif |
dc.contributor.author | Wijkhuijs, Annemarie |
dc.contributor.author | Arolt, Volker |
dc.date.accessioned | 2020-02-20T13:51:07Z |
dc.date.available | 2020-02-20T13:51:07Z |
dc.date.issued | 2019-07-09 |
dc.identifier.citation | Arteaga-Henríquez G, Simon MS, Burger B, Weidinger E, Wijkhuijs A, Arolt V, et al. Low-grade inflammation as a predictor of antidepressant and anti-inflammatory therapy response in MDD patients: a systematic review of the literature in combination with an analysis of experimental data collected in the EU-Moodinflame consortium. Front Psychiatry. 2019 Jul 9;10:458. |
dc.identifier.issn | 1664-0640 |
dc.identifier.uri | https://hdl.handle.net/11351/4668 |
dc.description | Teràpia antiinflamatòria; Teràpia antidepressiva; Inflamació |
dc.description.sponsorship | This study was financially supported by the EU via the MOODINFLAME project (EU-FP7-HEALTH-F2-2008-222963), the PSYCHAID (EU-FP7-PEOPLE-2009-IAPP-MarieCurie-286334), and the MOODSTRATIFICATION project (H2020-EU. 3.1.1., GA754740). NM and GA were additionally supported by the foundation "Immunitat und Seele." The funders had no role in study design, data collection, analysis and interpretation of data, the writing of the report, and the decision to submit the paper for publication. |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Psychiatry;10 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Inflamació - Mediadors |
dc.subject | Antidepressius |
dc.subject | Antiinflamatoris |
dc.subject.mesh | Inflammation Mediators |
dc.subject.mesh | Antidepressive Agents |
dc.subject.mesh | Anti-Inflammatory Agents |
dc.title | Low-grade inflammation as a predictor of antidepressant and anti- inflammatory therapy response in MDD patients: a systematic review of the literature in combination with an analysis of experimental data collected in the EU-MOODINFLAME consortium |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fpsyt.2019.00458 |
dc.subject.decs | mediadores de la inflamación |
dc.subject.decs | antidepresivos |
dc.subject.decs | antiinflamatorios |
dc.relation.publishversion | https://www.frontiersin.org/articles/10.3389/fpsyt.2019.00458/full |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Arteaga-Henríquez G] Department of Psychiatry and Psychotherapy, University Hospital, Ludwig-Maximilian-University, Munich, Germany. Department of Immunology, Erasmus Medical Center, Rotterdam, Netherlands. Grup de recerca en Psiquiatria, salut mental i addiccions, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Simon MS, Weidinger E] Department of Psychiatry and Psychotherapy, University Hospital, Ludwig-Maximilian-University, Munich, Germany. [Burger B] Marion von Tessin Memory-Center, Munich, Germany. [Wijkhuijs A] RMS, Rotterdam, Netherlands. [Arolt V] Department of Psychiatry and Psychotherapy, University Hospital of Muenster, Muenster, Germany |
dc.identifier.pmid | 31354538 |
dc.identifier.wos | 000474758800001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |